Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

Mersana

Mersana is rewriting the rules for ADC therapies by leveraging our Fleximer platform to create precisely targeted and highly tailored drugs that radically improve patients' lives.

Search Projects